2019 Partnership Forum Series

PartnershipForum_header 

The live, hands-on AMCP Partnership Forums bring key decision-makers in managed care, integrated care, the pharmaceutical industry, and others together to discuss and collaborate on tactics and strategies to drive efficiencies and outcomes. 

Designed to address current market challenges and opportunities, the AMCP Partnership Forums:   

  • Take a proactive, collaborative approach to solving important issues and challenges  

  • Represent opportunities for payers, manufacturers, and other stakeholders to work together on common goals and interests, and create actionable results  

  • Gain consensus on tactics to address key challenges or opportunities, as well as how to remove barriers to improve patient care and optimize value for all stakeholders  

  • Have high visibility among industry stakeholders and policy-makers  

2019 Forum Topics:


Pharmacy and Therapeutics (P&T) Practices: What’s Next?

It has been nearly 20 years since AMCP and other stakeholders adopted the Principles for a Sound Formulary System. Since that time, requirements for pharmacy and therapeutics committees (P&T) have been adopted by the Medicare Part D program, health insurance marketplace plans, commercial health plans, Medicaid programs, and other public payers. Changes and evolution in the health care system, including a focus on value-based care, suggest the need for updated recommendations from a broad stakeholder coalition. This Forum will provide a venue to consider P&T practices that reflect the current health care system and provide recommendations to allow for a transparent P&T process in today’s health care system.

March 2019 | San Diego, CA

 


Optimizing Prior Authorization for Appropriate Medication Selection

We will examine how to improve decision making for prior authorization and step therapy based on current market dynamics and considerations to ensure patients receive the most appropriate medications. The forum will develop multi-stakeholder recommendations including: the impact of PA on patient outcomes, the return on investment for technology adoption, and ways to ensure good outcomes through policy and activities by the health care system.

Date TBD

 


What’s Next for Specialty Medication Benefit Design and Reimbursement

Current inefficiencies in the health care system create administrative burdens for patients, providers, and payers, and often result in additional unnecessary costs. As a result, the government and private sectors are examining new reimbursement and benefit designs to pay for medications, including re-examining the Medicare Part B and Medicaid programs. Before implementing major changes, however, stakeholders must carefully analyze the potential impact these reforms will have on patient care, access to medications, and the overall health care system. This forum will make recommendations and considerations for ways that benefit design and reimbursement may evolve without compromising patient access and care.

Date TBD

 


Digital Therapies: What are they and Where do they fit in Pharmacy and Medical Benefits?

Digital therapies with web and designed based applications are emerging as a means to treat conditions by engaging people to improve health and wellness. In some cases, these therapies are preventive to stop a disease or improve outcomes in certain chronic conditions including cancer, diabetes, and heart disease. Other areas for digital therapies have emerged for birth control and to manage opioid addiction. They typically focus on ways to modify a person’s environment or behavior to increase patient engagement, improve adherence to medications and possibly reduce hospitalizations or prevent other expensive health interventions. But where do these fit in terms of a pharmacy or a medical benefit for insurance coverage? This partnership forum will consider these important emerging issues to provide recommendations to inform this growing area..

Date TBD


Partnershipforum_backgroundbanner 
 
 
Content for class "break" Goes Here